Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1231-1240 of 11530

Edit search filters
  1. Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer that has been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

    Rochester, MN, Scottsdale/Phoenix, AZ

  2. Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects

    Rochester, MN

  3. An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects

    Rochester, MN

  4. A Study of Vutrisiran (ALN-TTRSC02) in Patients with Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

    Rochester, MN

  5. Ocular Hypertension Treatment Study (OHTS)

    Rochester, MN

  6. MBI Response toTam

    Rochester, MN

  7. Ketamine and Kidney Injury in Cardiac Surgery

    Rochester, MN

  8. TOCCASTAR - TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

  9. A Long Term Safety Study of BCX7353 in Hereditary Angioedema

    Rochester, MN

  10. A Study to Evaluate TVB-2640 and Trastuzumab Plus Paclitaxel or Endocrine Therapy for Treating Patients with HER2 Positive Advanced Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer